• 2'3'-cGAMP: Practical STING Assay Workflows

  2026-09-20

  Use 2'3'-cGAMP (sodium salt) as a high-affinity benchmark for STING activation, pathway-competence testing, and extracellular cGAMP degradation assays. Its value is especially clear in exosome and ENPP1 studies, where separating ligand activity from ligand loss can reveal mechanisms of tumor immune evasion.

• 2'3'-cGAMP (sodium salt) for Reliable Assays

  2026-09-19

  Learn how 2'3'-cGAMP (sodium salt), SKU B8362, can improve experimental control in viability, proliferation, cytotoxicity, and innate-immunity workflows. This scenario-based guide covers aqueous formulation, STING biology, protocol planning, data interpretation, and practical vendor-selection criteria.

• Mubritinib–HSA Binding: Mechanistic Insights

  2026-09-18

  The reference study defines how the mitochondrial electron transport chain inhibitor mubritinib interacts with human serum albumin through complementary spectroscopic, biochemical, and docking analyses. Its findings connect moderate, site-specific protein binding with fluorescence changes, structural perturbation, and reduced albumin esterase-like activity, providing a pharmacokinetic framework for interpreting mubritinib disposition.

• From Epitope Competition to Translational Insight

  2026-09-18

  A mechanistic guide to using the c-Myc tag peptide as an assay-control reagent while interpreting transcription-factor stability, autophagy, and translational biology with appropriate evidence boundaries.

• 3-Deazaadenosine for Methylation Research

  2026-09-17

  Use 3-Deazaadenosine as an acute, reversible S-adenosylhomocysteine hydrolase inhibitor to perturb methylation-dependent biology without conflating global methylation pressure with METTL14-specific regulation. This workflow connects ulcerative colitis pathway discovery with carefully bounded preclinical antiviral research and practical assay controls.

• 2'3'-cGAMP: Beyond Canonical STING Biology

  2026-09-17

  2'3'-cGAMP (sodium salt) is more than a potent STING agonist: it is a mechanistic probe for connecting cGAS-STING signaling, type I interferon induction, and emerging noncanonical biology. This thought-leadership analysis translates recent 2'3'-cGAMP interactome findings into practical guidance for immunology, cancer, and translational research programs.

• ARCA Cy5 EGFP mRNA (5-moUTP) Guide

  2026-09-16

  Learn how ARCA Cy5 EGFP mRNA (5-moUTP), SKU R1009, separates mRNA uptake from translation in mammalian-cell viability and delivery studies. This scenario-based guide covers experimental design, handling, data interpretation, and practical vendor selection using product specifications and a peer-reviewed mRNA LNP workflow.

• Cannabidiol in Orofacial Pain: Mechanisms and Implications

  2026-09-16

  This 2026 study shows that cannabidiol reduces inflammatory pain across sensory, affective, and cognitive domains through distinct peripheral, central, endocannabinoid, and serotonergic mechanisms. Its design provides a useful framework for connecting pain behavior with molecular and circuit-level measurements while highlighting where receptor-specific causal tests remain necessary.

• E-64d Workflows for Calpain and Cell-Death Studies

  2026-09-15

  E-64d is a cell-permeable, irreversible cysteine protease inhibitor suited to separating calpain- and cathepsin-dependent phenotypes from broader cell-death effects. This workflow combines careful dose preparation with time-resolved measurements inspired by MEDUSA, improving interpretation in platelet, apoptosis, neuroprotection, and cancer research.

• Cell Counting Kit-8 (CCK-8) Lab Guide

  2026-09-15

  This scenario-driven guide explains how Cell Counting Kit-8 (CCK-8), SKU K1018, can address common variability in cell viability, proliferation, and cytotoxicity workflows. It connects assay chemistry with experimental controls, protocol optimization, interpretation, and practical product selection for biomedical research.

• REC8 Stabilizes MAVS and STING in Antiviral Immunity

  2026-09-14

  Chen and colleagues identify REC8 as an unexpected positive regulator of antiviral innate immunity. Their findings connect SUMO-dependent REC8 relocalization with protection of MAVS and STING from RNF5-driven K48-linked ubiquitination, clarifying how adaptor stability can reinforce type I interferon induction.

• EdU Flow Cytometry Assay Kits (Cy5)

  2026-09-14

  EdU Flow Cytometry Assay Kits (Cy5) provide a practical way to measure DNA synthesis during S-phase using EdU incorporation and Cy5 click-chemistry detection. This dossier-based workflow is suitable for research applications such as cell proliferation, genotoxicity, and pharmacodynamic studies, but it should not be used as a standalone clinical diagnostic or in vivo labeling method.

• Mcl-1 Epigenetic Targeting in Glioblastoma

  2026-09-13

  The reference study identifies a super-enhancer at the MCL1 locus as a determinant of apoptotic resistance in glioblastoma and shows that its disruption sensitizes tumor models to BCL-2/BCL-xL inhibition. By combining ChIP-seq, THZ1 treatment, BH3 mimetics, mitochondrial apoptosis readouts, and patient-derived xenografts, the work provides a mechanistic framework for co-targeting transcriptional regulation and anti-apoptotic signaling.

• Alfuzosin HCl: Bench-to-Formulation Workflows

  2026-09-12

  Build reproducible Alfuzosin HCl assays that connect α1-receptor pharmacology with dissolution, gastroretention, and analytical quality control. This workflow translates the reference study’s low-density sponge platform into practical formulation screens, release tests, and troubleshooting decisions.

• 2'3'-cGAMP: Designing Better STING Assays

  2026-09-11

  2'3'-cGAMP (sodium salt) is a precise tool for dissecting cGAS-STING signaling pathway activity. This guide explains how ligand chemistry, endothelial signaling, and assay architecture shape interpretable immunotherapy research results.

8526 records 1/569 page Next 12345 下5页 Last page